| | Recent research reporting profitable translation of stem cell therapies to patients have enriched the hope that such regenerative strategies might in the future grow to be a remedy for a variety of vexing diseases (2). In actual fact, the previous few years witnessed, a slightly exponential development in clinical trials revolving round stem cell-based mostly therapies. A few of these trials resulted in exceptional influence on varied diseases (3). For instance, a case of Epidermolysis Bullosa manifested indicators of skin restoration after therapy with keratinocyte cultures of epidermal stem cells (4). Also, a significant enchancment in eyesight of patients affected by macular degeneration was reported after transplantation of patient-derived induced pluripotent stem cells (iPSCs) that have been induced to differentiate into pigment epithelial cells of the retina (5).
|